Home - Products - Others - Other Targets - Degarelix acetate(214766-78-6 free base)

Degarelix acetate(214766-78-6 free base)

CAS No. 934016-19-0

Degarelix acetate(214766-78-6 free base)( —— )

Catalog No. M32879 CAS No. 934016-19-0

Degarelix acetate is a competitive and reversible antagonist of gonadotropin-releasing hormone receptor (GnRHR) .

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 95 In Stock
5MG 160 In Stock
10MG 266 In Stock
25MG 478 In Stock
50MG 681 In Stock
100MG 918 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Degarelix acetate(214766-78-6 free base)
  • Note
    Research use only, not for human use.
  • Brief Description
    Degarelix acetate is a competitive and reversible antagonist of gonadotropin-releasing hormone receptor (GnRHR) .
  • Description
    Degarelix acetate is a competitive and reversible antagonist of gonadotropin-releasing hormone receptor (GnRHR) .
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    GNRH Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    934016-19-0
  • Formula Weight
    1692.34
  • Molecular Formula
    C84H107ClN18O18
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC(O)=O.CC(C)C[C@H](NC(=O)[C@@H](Cc1ccc(NC(N)=O)cc1)NC(=O)[C@H](Cc1ccc(NC(=O)[C@@H]2CC(=O)NC(=O)N2)cc1)NC(=O)[C@H](CO)NC(=O)[C@@H](Cc1cccnc1)NC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(C)=O)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Angelol H

    Angelol H is a natural product from Angelica sinensis.

  • Apraglutide TFA (129...

    Apraglutide TFA (FE 203799 TFA), a synthetic 33-amino-acid peptide and a long-acting GLP-2 analogue, enhances adaptation and linear intestinal growth in a neonatal piglet model of short bowel syndrome with total resection of the ileum.

  • PHA-767491

    PHA-767491 is a potent ATP-competitive dual Cdc7/CDK9 inhibitor with IC50 of 10 nM and 34 nM, respectively.